A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Dyne Therapeutics Inc (Symbol: DYN) entered into oversold territory, hitting an RSI reading ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Dyne Therapeutics Inc. is back with another personnel announcement, appointing Erick Lucera as chief financial officer. Lucera comes to the Waltham company (Nasdaq: DYN) from Editas Medicine.

Sarepta’s news came as several companies—including Dyne Therapeutics, REGENXBIO and Genethon—presented new data on their next-generation exon-skipping therapies and gene therapies for Duchenne ...

Treatment with DYNE-101 is leading to improvements in muscle function — with notable gains in finger function — among people with myotonic dystrophy type 1 (DM1) in a Phase 1/2 clinical trial, ...